(Q44657553)

5 December 2017

Role of adiponectin in insulin-resistant hypertension and atherosclerosis (English)

1 reference

5 December 2017

Role of Adiponectin in Insulin-Resistant Hypertension and Atherosclerosis (English)

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.705

2 April 2024

1 reference

1 reference

intercellular signaling peptides and proteins

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14620925

Cardiology and cardiovascular medicine

2 April 2024

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.705

2 April 2024

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.705

2 April 2024

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.705

2 April 2024

3

Masato Furuhashi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14620925

2 April 2024

5

Tetsuji Miura

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14620925

2 April 2024

author name string

Hideyuki Murakami

1

1 reference

5 December 2017

Nobuyuki Ura

2

1 reference

5 December 2017

Katsuhiro Higashiura

4

1 reference

5 December 2017

Kazuaki Shimamoto

6

1 reference

5 December 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14620925

2 April 2024

publication date

1 September 2003

1 reference

full work available at URL

5 December 2017

https://www.jstage.jst.go.jp/article/hypres/26/9/26_9_705/_pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14620925

2 April 2024

published in

Hypertension Research

1 reference

5 December 2017

26

1 reference

5 December 2017

705-710

1 reference

5 December 2017

9

1 reference

https://scigraph.springernature.com/pub.10.1291/hypres.26.705

5 December 2017

0 references

cites work

Banting lecture 1988. Role of insulin resistance in human disease

1

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.705

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

2 April 2024

2

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.705

Hyperinsulinemia as an independent risk factor for ischemic heart disease.

2 April 2024

3

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.705

Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease

2 April 2024

4

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.705

Epidemiology of insulin resistance and its relation to coronary artery disease

2 April 2024

5

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.705

Insulin resistance and angiographical characteristics of coronary atherosclerosis.

2 April 2024

6

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.705

Cardiovascular morbidity and mortality associated with the metabolic syndrome

2 April 2024

7

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.705

Role of hyperinsulinemia in atherosclerotic coronary arterial disease: studies of semi-quantitative coronary angiography.

2 April 2024

8

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.705

Insulin resistance in essential hypertension

2 April 2024

9

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.705

Insulin sensitivity and the effects of insulin on renal sodium handling and pressor systems in essential hypertensive patients.

2 April 2024

10

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.705

Insulin resistance and systemic hypertension

2 April 2024

11

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.705

Insulin resistance and hypertension in Japanese

2 April 2024

12

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.705

Tissue-specific impairment of insulin signaling in vasculature and skeletal muscle of fructose-fed rats

2 April 2024

13

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.705

Adipogenesis and obesity: rounding out the big picture

2 April 2024

14

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.705

Leptin and the regulation of body weight in mammals

2 April 2024

16

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.705

The hormone resistin links obesity to diabetes

2 April 2024

17

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.705

The contribution of skeletal muscle tumor necrosis factor-alpha to insulin resistance and hypertension in fructose-fed rats.

2 April 2024

18

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.705

Association of insulin resistance and hyperinsulinemia with disturbed lipid metabolism in patients with essential hypertension.

2 April 2024

19

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.705

Insulin signalling and the regulation of glucose and lipid metabolism

2 April 2024

20

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.705

Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity

2 April 2024

21

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.705

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia

2 April 2024

22

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.705

An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls

2 April 2024

23

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.705

Disruption of adiponectin causes insulin resistance and neointimal formation

2 April 2024

24

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.705

A novel serum protein similar to C1q, produced exclusively in adipocytes

2 April 2024

25

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.705

Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma

2 April 2024

26

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.705

AdipoQ is a novel adipose-specific gene dysregulated in obesity

2 April 2024

27

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.705

cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1).

2 April 2024

28

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.705

Structural biology of cadherins in the nervous system

2 April 2024

29

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.705

Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys

2 April 2024

30

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.705

The adipocyte-secreted protein Acrp30 enhances hepatic insulin action

2 April 2024

32

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.705

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

2 April 2024

33

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.705

Rebirth of the health-care system in Cambodia

2 April 2024

34

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.705

Insulin resistance as the core defect in type 2 diabetes mellitus

2 April 2024

35

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.705

Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin

2 April 2024

36

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.705

Cellular mechanisms of insulin resistance

2 April 2024

37

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.705

Fenofibrate improves insulin sensitivity in connection with intramuscular lipid content, muscle fatty acid-binding protein, and beta-oxidation in skeletal muscle

2 April 2024

38

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.705

Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis

2 April 2024

39

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.705

Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients.

2 April 2024

40

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.705

Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin

2 April 2024

42

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.705

Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway

2 April 2024

43

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.705

Influences of ionomycin, dibutyryl-cycloAMP and tumour necrosis factor-alpha on intracellular amount and secretion of apM1 in differentiating primary human preadipocytes

2 April 2024

44

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.705

Adiponectin gene expression is inhibited by beta-adrenergic stimulation via protein kinase A in 3T3-L1 adipocytes

2 April 2024

45

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.705

PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein

2 April 2024

46

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.705

Secretion of adiponectin and regulation of apM1 gene expression in human visceral adipose tissue

2 April 2024

47

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.705

Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes

2 April 2024

48

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.705

Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein

2 April 2024

49

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.705

The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance

2 April 2024

50

1 reference

https://api.crossref.org/works/10.1291/HYPRES.26.705

2 April 2024

Identifiers

1 reference

Dimensions Publication ID

5 December 2017

0 references

1 reference